Yew Bio-Pharm Group, Inc. (YEWB) Financial Statements
Yew Bio-Pharm Group, Inc. (YEWB) files with the U.S. Securities and Exchange Commission under CIK 0001548240. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2020
- Revenue
- $27.31 million
- Net Income
- $1.46 million
- Total Assets
- $58.45 million
- Net Cash from Operations
- $17.34 million
Fiscal year ended Dec 31, 2020. Latest periodic SEC filing: Nov 15, 2021. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for YEWB in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History